Japanese initiative for education in pharmaceutical medicine and clinical research training
DOI:
https://doi.org/10.18063/jmds.v2i2.166Keywords:
PharmaTrain, CLIC, CREDITS, JAPhMed, SMD, pharmaceutical medicine, learning management system, continuous educationAbstract
Development of new medicines has become increasingly difficult with less possibility of success in seeds-finding and ever rising operational costs. Failure to comply with ethical standards for human research protection also erodes social trust in clinical development. In order to develop competence of professionals in medicines development such as clinical investigators and drug development scientists, a variety of educational courses and training programs have been developed and executed worldwide. As Japan is no exception and shares the same concerns, significant governmental and non-governmental efforts have been made to invest in the development of academic educational courses and adherence to international standards. This article introduces examples of the adoption of technologies to realize a user-friendly and sustainable learning management as well as an adaptation of syllabuses and core curricula to meet international standards in the era of global medicines development.
References
PharmaTrain manual curriculum standards and best practices ver. 2.0, 2014, n.d., viewed October 15, 2016. http://www.PharmaTrain.eu/165.php
DiMasi J A, Grabowski H G, Hansen R W, 2016, Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47: 20–33. http://dx.doi.org/10.1016/j.jhealeco.2016.01.012
Nosengo N, 2016, Can you teach old drugs new tricks? Nature, 534(7607): 314–316. http://dx.doi.org/10.1038/534314a
Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK., n.d., viewed October 15, 2016.
Dubois D J, Jurczynska A, Kerpel-Fronius S, et al. 2016, Fostering competence in medicines development: The IFAPP perspective. Frontiers in Pharmacology, 7: 377. http://dx.doi.org/10.3389/fphar.2016.00377
PharmaTrain mastering medicine development, n.d., viewed October 15, 2016. http://www.PharmaTrain.eu
Ono S, Tsutani K, Shibata T, et al. 2003, Clinical trials in Japan after implementation of the International Conference on Harmonization—Good Clinical Practice (ICHGCP) guidelines, Pharmaceutical Development and Regulation, 1(2): 81–89. http://dx.doi.org/10.1007/BF03257368
Pacific Bridge Medical, 2013, Japan 5-years clinical research and trial activation plan 2012, n.d., viewed September 28, 2016. http://www.pacificbridgemedical.com/news-brief/japan5-years-clinical-research-and-trial-activation-plan-2012/
University Hospital Medical Information Network Center, n.d., viewed September 28, 2016. http://www.umin.ac.jp/english/whatisumin.htm
Clinical Data Interchange Standard Consortium, n.d., viewed September 28 2016. http://www.cdisc.org/
Pharmaceuticals and Medical Devices Agency, n.d, viewed September 28, 2016. http://www.pmda.go.jp/english/index.html
Moodle, n.d., viewed September 28, 2016. https://moodle.org/
Ministry of Health, Labour and Welfare, The ethical guidelines for medical and health research involving human subjects: Provisional translation (as of March 2015). http://www.mhlw.go.jp/file/06-Seisakujouhou-1060000
-Daijinkanboukouseikagakuka/0000080278.pdf
Swissethics, List of Swissethics recognized Research Ethics and GCP course providers. http://www.swissethics.ch/fortbildung_e.html
Koren M J, Koski G, Reed D P, et al. 2011, Statement of clinical investigator competence, APCR consensus statement. The Monitor, 25(4): 79–82.
European Science Foundation, 2003, A European syllabus for training clinical investigators, viewed October 24, 2016.
Boeynaems J M, Canivet C, Chan A, et al. 2013, A European approach to clinical investigator training. Frontiers in Pharmacology, 4: 112. http://dx.doi.org/10.3389/fphar.2013.00112
eCLIC: an online course for clinical investigators and their teams, n.d., viewed October 20, 2016. http://clic.bio-med.ch/cms/Default.aspx?Page=10500&Menu=103&backbar=0
CITI-Japan Program, Responsible conduct of research (RCR), n.d., viewed October 20, 2016. https://edu.citiprogram.jp/japan/H28_elearning_list.pdf
PharmaTrain specialist in medicines development (SMD) procedural document, 2014, n.d., viewed October 15, 2016. http://www.pharmatrain.eu/_downloads/Appendix_12_8_SMD_Procedural_Document_V1_0.pdf>
Silva H, Stonier P, Buhler F, et al. 2013, Core competencies for pharmaceutical physicians and drug development scientists. Frontiers in Pharmacology, 4: 105. http://dx.doi.org/10.3389/fphar.2013.00105